[Molecular mechanisms of highly pathogenic viruses' replication and their applications for a novel drug discovery]

Uirusu. 2020;70(1):69-82. doi: 10.2222/jsv.70.69.
[Article in Japanese]

Abstract

Productive (lytic) replication of DNA viruses elicits host cell DNA damage responses, which cause both beneficial and detrimental effects on viral replication. Viruses utilize them and selectively cancel the 'noisy' downstream signaling pathways, leading to maintain high S-phase CDK activities required for viral replication. To achieve this fine tuning of cellular environment, herpesviruses encode many (>70) genes in their genome, which are expressed in a strictly regulated temporal cascade (immediate-early, early, and late). Here, I introduce and discuss how Epstein-Barr virus, an oncogenic herpesvirus, hijacks the cellular environment and adapt it for the progeny production.

MeSH terms

  • DNA Replication
  • Drug Discovery
  • Epstein-Barr Virus Infections*
  • Herpesvirus 4, Human* / genetics
  • Humans
  • Phosphorylation
  • Virus Replication / genetics